Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Retatrutide, an experimental triple-agonist peptide drug targeting obesity, has demonstrated superior weight-loss efficacy in Phase II trials compared to existing FDA-approved medications like semaglutide (Wegovy) and tirzepatide (Mounjaro). Developed by ... Read More
Continuous Coverage
The man from Saanich, British Columbia, stood before the judge with a name that would soon become synonymous…
An Irish emergency physician stationed in the Democratic Republic of Congo has raised alarms about the accelerating Ebola…
Roger Federer’s return to the Laver Cup in London marks a pivotal moment for tennis legacy, team dynamics,…
Jack Antonoff’s new Bleachers album, *Everyone for Ten Minutes*, lands this weekend as a sonic middle finger to…
Humanoid robots are entering the workforce at scale, threatening 15-20% of global labor roles by 2030—starting with manufacturing,…
The U.S. Treasury has imposed sanctions on nine Lebanese figures—including politicians, security officials, and alleged Hezbollah operatives—accusing them…
Global Affairs
The Pentagon has pushed Canada for a swift decision on F-35 procurement, highlighting tensions between national sovereignty and…
Markets And Money
Egypt’s gold market stabilized Friday, May 22, 2026, with 24-karat gold trading at EGP 7,789 per gram—a 0.3%…
Digital Culture
Google and Samsung are finalizing a strategic pivot into the smart eyewear market, targeting a 2026 launch to…
Science And Wellbeing
Umeå University has secured 12 million SEK ($1.1 million USD) to advance rehabilitation research, focusing on post-stroke motor…
Screen And Sound
Married at First Sight’s Rob Geus (58) reflects on his 2024 altar rejection by Sandra Witt, admitting the…
Fixtures And Form
Slovak international defender Ľubomír Šatka is officially departing Samsunspor as he seeks a new professional challenge following the…
